Lumicell Promotes Marnie Curbow as Chief Commercial Officer to Drive Next Phase of Growth Waltham, MA – Lumicell, Inc., a leader in developing innovative fluorescence-guided imaging technologies for cancer detection,

Seattle, WA — May 1, 2026 — Lumicell, a leader in intraoperative fluorescence imaging technology for breast cancer surgery, announced today its expanded presence at the American Society of Breast

Waltham, MA — April 2026 — Lumicell, Inc., a leader in developing innovative fluorescence-guided imaging technologies for cancer detection, announced today that it will be featured on Health Uncensored with

Newton, MA  [February 4, 2026] — Lumicell, Inc., a leader in developing innovative fluorescence-guided imaging technologies for cancer detection, today announced the appointment of Cheryl R. Blanchard, Ph.D., to its

Los Angeles, January 8, 2026 – Global Team Will Launch Gastric Cancer Prevention Clinical Trial. CAUTION – Investigational device and new drug. Limited by Federal (or United States) law to

Newton, MA — December 18, 2025 — Lumicell, Inc., a leader in developing innovative fluorescence-guided imaging technologies for cancer detection, today announced a new collaboration with Learn Look Locate, a

Pioneering real-time detection of cancer brings promise to enabling a more complete resection in gastrointestinal cancer surgery Newton, MA – Lumicell, Inc., a leader in developing innovative fluorescence-guided imaging technologies for

LumiSystem is the first and only fluorescence-guided imaging technology for breast cancer detection, enabling a more complete resection Newton, MA – Lumicell, Inc., a leader in developing innovative fluorescence-guided imaging

Independent director, Jim Alecxih, Chief Executive Officer of DH Medical joins Lumicell’s Board of Directors NEWTON, Mass., Jan. 6, 2025 – Lumicell, Inc., a privately held company focused on developing innovative